Recent developments in the management of severe asthma.

Howraman Meteran Louise Lindhardt ToennesenPradeesh SivapalanTruls Sylvan IngebrigtsenJens-Ulrik Stæhr Jensen

Published in: Breathe (Sheffield, England) (2022)

Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4.

Keyphrases

current status
replacement therapy
smoking cessation